Related references
Note: Only part of the references are listed.Multiparameter flow cytometry for the identification of the Waldenstrom's clone in IgM-MGUS and Waldenstrom's Macroglobulinemia: new criteria for differential diagnosis and risk stratification
B. Paiva et al.
LEUKEMIA (2014)
Multiple myeloma: 2013 update on diagnosis, risk-stratification, and management
S. Vincent Rajkumar
AMERICAN JOURNAL OF HEMATOLOGY (2013)
MYD88 (L265P) mutation is an independent risk factor for progression in patients with IgM monoclonal gammopathy of undetermined significance
Marzia Varettoni et al.
BLOOD (2013)
MYD88 L265P mutation in Waldenstrom macroglobulinemia
Stephanie Poulain et al.
BLOOD (2013)
Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenstrom's macroglobulinemia and related lymphoid neoplasms
Marzia Varettoni et al.
BLOOD (2013)
MYD88 L265P in Waldenstrom macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction
Lian Xu et al.
BLOOD (2013)
Response assessment in Waldenstrom macroglobulinaemia: update from the VIth International Workshop
Roger G. Owen et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Bruton tyrosine kinase inhibitors: a promising novel targeted treatment for B cell lymphomas
Amin Aalipour et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenstrom macroglobulinemia/lymphoplasmacytic lymphomas
N. Gachard et al.
LEUKEMIA (2013)
MYD88 L265P is a marker highly characteristic of, but not restricted to, Waldenstrom's macroglobulinemia
C. Jimenez et al.
LEUKEMIA (2013)
Frequency and distribution of lymphoma types in a tertiary care hospital in South India: analysis of 5115 cases using the World Health Organization 2008 classification and comparison with world literature
Neeraj Arora et al.
LEUKEMIA & LYMPHOMA (2013)
Significant Male Preponderance in Childhood Acute Lymphoblastic Leukemia in India and Regional Variation: Tertiary Care Center Experience, Systematic Review, and Evaluation of Population-Based Data
Ketan Prasad Kulkarni et al.
PEDIATRIC HEMATOLOGY AND ONCOLOGY (2013)
Waldenstrom's macroglobulinemia: Treatment approaches for newly diagnosed and relapsed disease
Lucy S. Hodge et al.
TRANSFUSION AND APHERESIS SCIENCE (2013)
Histopathological pattern of lymphomas and clinical presentation and outcomes of diffuse large B cell lymphoma: A multicenter registry based study from India
Ramesh B. V. Nimmagadda et al.
INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY (2013)
Waldenstrom Macroglobulinemia: 2012 update on diagnosis, risk stratification, and management
Morie A. Gertz
AMERICAN JOURNAL OF HEMATOLOGY (2012)
MYD88 L265P Somatic Mutation in Waldenstrom's Macroglobulinemia
Steven P. Treon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
International prognostic scoring system for Waldenstrom macroglobulinemia
Pierre Morel et al.
BLOOD (2009)
South Asian chronic lymphocytic leukaemia patients have more rapid disease progression in comparison to White patients
Chaminda Gunawardana et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Chronic lymphocytic leukemia in India - A clinico-hematological profile
Neerja Agrawal et al.
HEMATOLOGY (2007)
Distribution and clinicopathologic characteristics of non-Hodgkin's lymphoma in India: a study of 935 cases using WHO classification of lymphoid neoplasms (2000)
Charandeep S. Sahni et al.
LEUKEMIA & LYMPHOMA (2007)
Use of the World Health Organization (WHO) classification of non-Hodgkin's lymphoma in Mumbai, India: A review of 200 consecutive cases by a panel of five expert hematopathologists
KN Naresh et al.
LEUKEMIA & LYMPHOMA (2004)
Share Paper
